Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Filspari
Pharma
Travere pauses trial enrollment over manufacturing scale-up woes
San Diego’s Travere Therapeutics has run into trouble with its enzyme replacement candidate pegtibatinase thanks to manufacturing scale-up issues.
Fraiser Kansteiner
Sep 27, 2024 9:26am
Despite trial scare, Travere's IgAN drug wins full FDA approval
Sep 5, 2024 5:40pm
Novartis rides IgAN trioka to trial wins in rare kidney diseases
May 28, 2024 11:20am
EU regulator says yes to Tavere's Filspari, several other meds
Feb 23, 2024 12:12pm
Travere cuts 20% of workforce, aims to win full nod for Filspari
Dec 5, 2023 11:26am
Travere looks to consistent benefit to stay in kidney disease
Nov 3, 2023 10:34am
